• Clodronate Liposomes for In Vivo Macrophage Studies

  2026-09-24

  Use Clodronate Liposomes to test whether macrophages are necessary for an in vivo phenotype, while PBS liposomes help separate clodronate effects from liposome exposure. The workflow pairs depletion checks with functional phagocytosis assays—an important distinction when studying age-related changes in macrophage activity.

• SVP3 from Sanghuangporus vaninii: Lipid Effects

  2026-09-24

  A study in Carbohydrate Polymers characterized SVP3, a neutral hetero-galactan purified from Sanghuangporus vaninii, and found that it improved several lipid and tissue outcomes in hyperlipidemic mice. Integrated gut microbiota, serum metabolomics, and liver proteomics linked these effects to inflammation-associated TLR4/NF-κB signaling, although the findings remain preclinical and do not establish a treatment for human hyperlipidemia.

• Sodium Ascorbate Workflows for Cancer Research

  2026-09-23

  Build reproducible ROS and tumor-cell response assays with Sodium Ascorbate, from fresh stock preparation to orthogonal viability and motility readouts. The workflow keeps glioblastoma evidence distinct from an ESCC immunotherapy biomarker study, while showing how its experimental-design lessons can inform stronger assay controls.

• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-09-23

  Turn weak immunoblot bands into a more reliable quantitative workflow with extended signal duration, low background, and compatibility with diluted antibodies. This guide shows how to apply hypersensitive ECL to pathway validation, low-abundance targets, and follow-up experiments inspired by a recent Sanghuangporus vaninii study.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-22

  Shapira-Netanelov and colleagues developed a patient-derived gastric cancer assembloid that combines matched tumor organoids with stromal subpopulations from the same tumor. The model reproduced tumor–stroma-dependent gene expression and drug-response differences, providing a more physiologically relevant platform for biomarker discovery, resistance studies, and personalized therapy screening.

• BMS-777607: From MET Biology to Translational Models

  2026-09-22

  BMS-777607 offers a defined way to interrogate MET-family signaling across cancer metastasis models and emerging hiPSC-derived platelet workflows. This thought-leadership guide connects kinase selectivity, experimental validation, formulation strategy, and translational decision-making without overstating preclinical evidence.

• Sildenafil Citrate: A Proteoform-Aware Strategy

  2026-09-21

  Sildenafil Citrate is more than a conventional PDE5 tool: it can connect cGMP biology, vascular phenotypes, ERK signaling, and proteoform-resolved drug interactions. This thought-leadership guide outlines how translational researchers can use the compound to distinguish biochemical potency from cellular mechanism, native-membrane selectivity, and disease-model relevance.

• Pyridostigmine Targets Placental Necroptosis in PE

  2026-09-21

  The reference study identifies placental necroptosis as a therapeutically relevant feature of preeclampsia-like disease and shows that pyridostigmine improves pathological responses in a rat reduced uterine perfusion pressure model. Its pharmacological and cell-based experiments implicate α7 nicotinic acetylcholine receptor signaling as a link between cholinergic activity, reduced placental inflammation, and improved trophoblast function.

• Carvacrol: Mechanisms, Uses, and Research Workflow

  2026-09-20

  Carvacrol, also called 5-isopropyl-2-methylphenol, is a monoterpene phenol used in antibacterial, redox, cell cycle, and apoptosis research. Product specifications define its identity, solvent compatibility, and cold-chain handling, while a 2026 Redox Biology study places carvacrol among non-electrophilic TRPA1 agonists that help distinguish singlet-oxygen signaling from hydrogen-peroxide signaling.

• Fusobacterium EVs Prepare Colorectal Cancer Niches

  2026-09-19

  Zheng et al. show that extracellular vesicles from Fusobacterium nucleatum are enriched in colorectal cancer and help create tumor-cell surfaces that support bacterial adhesion. Their in vivo, clinical, and mechanistic evidence identifies vesicle-delivered FomA and its interaction with FN1441 as a pathway linking bacterial dissemination with intratumoral colonization.

• Alda 1: An Assay-First Guide to ALDH2 Biology

  2026-09-18

  Alda 1 is an ALDH2 activator that connects aldehyde detoxification with cardiac stress, cardiomyocyte proliferation, and radiation injury models. This assay-first guide explains how to separate acute protection from regenerative signaling and design genotype-aware experiments.

• Mouse Neutrophil Cell Isolation Kit: Practical Guide

  2026-09-18

  Build faster, activation-conscious neutrophil workflows for bone marrow, blood, and spleen samples. This guide shows how negative selection supports high-purity functional assays, including emerging neutrophil-targeted nanovaccine studies, while offering practical optimization and troubleshooting advice.

• Imidazoline Antagonists and β-Cell K+ Channels

  2026-09-17

  Jonas, Plant, and Henquin showed that imidazoline α2-adrenoceptor antagonists stimulate insulin release mainly by inhibiting ATP-sensitive K+ channels in mouse pancreatic β-cells, not simply by blocking adrenoceptors. Their combination of 86Rb efflux, whole-cell patch clamp, and pharmacological rescue experiments offers a useful framework for separating receptor-mediated effects from direct ion-channel actions.

• G007-LK Tankyrase 1/2 Inhibitor Workflow

  2026-09-17

  G007-LK turns tankyrase biology into a practical assay strategy for Wnt/β-catenin, APC-mutant colorectal cancer, and Hippo–YAP research. This guide connects dose-response design with degradasome, reporter, protein, and proliferation readouts while highlighting formulation and troubleshooting choices.

• Annexin-V Maps Cardiomyocyte Death After I/R

  2026-09-16

  The reference study introduced labeled recombinant human annexin-V as an in vivo marker of phosphatidylserine exposure during myocardial ischemia and reperfusion. Its quantitative time-course data showed that cardiomyocyte death increased with reperfusion and ischemic duration, while pharmacological intervention markedly reduced annexin-V-positive cells.

8351 records 1/557 page Next 12345 下5页 Last page